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Over the past four decades, the incidence of meningitis caused by Haemophilus
influenzae in children has decreased due to widespread vaccination against H. influenzae
type b (Hib). The incidence of invasive diseases due to H. influenzae types not included
in the vaccines, however, has increased. At present, there are a limited number
of diagnostics available to detect non-type b H. influenzae. To address this issue,
we developed a rapid, simple, and cost-effective method for detecting serotypes of
H. influenzae. We designed LAMP primer sets based on published sequences for
H. influenzae capsular types a, c, d, e, and f. The assay was evaluated to determine
test reactivity, specificity, and sensitivity. To support its use in patients with suspected
meningitis, we evaluated the detection limit of the non-Hib serotype specific LAMP
assay using bacterial genomic DNA-spiked cerebrospinal fluid (CSF) specimens. The
reactivity and specificity of the LAMP assays were confirmed using six serotypes and
non-typeable H. influenzae strains, plus eight strains of other Haemophilus species and
non-Haemophilus genera. The detection limits of the LAMP assay for capsular types a,
c, d, e, and f were 102, 102, 102, 103, and 10 copies per reaction, while those of the PCR
assay were 104, 104, 103, 103, and 104 genome copies per reaction, respectively. Using
DNA-spiked CSF specimens, the detection limit of the LAMP assay was equivalent to
that using purified DNA as the template. However, the detection limit of the PCR was
reduced from 103 to 104 genome copies per reaction for serotype d and from 103 to
105 genome copies per reaction for serotype e. To the best of our knowledge, this is the
first report of a serotype-specific identification assay for H. influenzae using the LAMP
method. Our results suggest the potential of LAMP methods for patients with suspected
meningitis in resource-limited laboratories or public health surveillance systems.
Keywords: loop-mediated isothermal amplification, Haemophilus influenzae, serotype identification, meningitis,
cerebrospinal fluid
Abbreviations: non-Hib, Haemophilus influenzae serotypes a, c, d, e and f.
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INTRODUCTION
Haemophilus influenzae causes meningitis, epiglottitis,
bacteremia, and pneumonia predominantly in infants and
young children (Peltola, 2000). Over the past two decades,
the introduction of Hib conjugate vaccines into routine
immunization schedules has dramatically reduced the incidence
of Hib-associated disease in many countries (Barbour, 1996).
The incidence of invasive diseases due to H. influenzae serotypes
not included in the vaccines (non-Hib strains), however, has
increased (Bajanca et al., 2004; Rahman et al., 2008; Rubach et al.,
2011).
Close monitoring of invasive H. influenzae disease continues
to be important in order to understand effectiveness of Hib
vaccines and detect emergence of invasive H. influenzae disease
due to non-Hib strains (Ulanova and Tsang, 2014; Desai
et al., 2015). To assess H. influenzae serotypes carriage, there
is a need for laboratory facilities that can reliably cultivate
H. influenzae and identify the capsular polysaccharide type using
immunological techniques. Such facilities are found in well-
equipped clinical microbiology laboratories, but serotyping of
the capsular antigen can produce inconsistent results (LaClaire
et al., 2003; Kim et al., 2011). Accurate H. influenzae serotyping
remains a challenge due to the limited availability of serotyping
methods of the capsular antigen and injudicious use of
antimicrobial agents. For this reason, a reliable, non-culture
based diagnostic test based on nucleic acid amplification methods
has the potential to offer an important option for detection of Hib
and non-Hib strains.
A PCR assay for H. influenzae serotyping (Falla et al., 1994)
has been established, however, PCR-based assays are relatively
expensive and complex to perform in resource-limited laboratory
settings. An alternative nucleic acid detection method known
as loop-mediated isothermal amplification (LAMP) utilizes a
unique priming mechanism that yields specific DNA products in
a shorter period of time than PCR (Notomi et al., 2000). A LAMP
method for detecting Hib has been established and its clinical
usefulness confirmed using clinical cerebrospinal fluid specimens
(CSF) (Kim et al., 2011).
The non-Hib serotyping LAMP method has the potential to
be more reliable and easier to perform than bacterial culture,
antigen detection, and PCR-based assays. However, to date,
a non-Hib-specific LAMP assay has not been reported. In
this study, we report the establishment of a novel non-Hib
serotyping LAMP assay, and compare its performance to that of
conventional PCR. We also confirmed the performance of the
non-Hib serotyping LAMP assay using DNA-spiked clinical CSF




Forty-two strains of H. influenzae (including serotypes
a to f, non-typeable and biotype aegyptius) plus eight
strains of other Haemophilus species and non-Haemophilus
genera were evaluated. Additional Haemophilus species were
H. parainfluenzae (HK79), H. parahaemolyticus (GTC1529),
and H. haemolyticus (HK680), and non-Haemophilus genera
were Streptococcus mitis (ATCC9811), S. gordonii (ATCC12396),
S. pneumoniae (R6), Escherichia coli (DH5α), and Neisseria
meningitidis (HY0001). In this study, 8 standard and 34 reference
H. influenzae strains (9 Hib, and 25 non-Hib serotypes, as
well as 8 non-typeable strains including 1 biotype aegyptius)
were evaluated (Table 1). The eight standard H. influenzae
strains were IID983 (serotype a), IID984 (serotype b), IID985
(serotype c), IID986 (serotype d), IID987 (serotype e), IID 988
(serotype f), IID989 (non-typeable) and IID993 (non-typeable,
biotype aegyptius). The 34 reference strains included 5 serotype
a (HK390, HK643, HK645, HK648, and HK649), 8 serotype b
(HK176, HK177, HK179, HK180, HK195, HK196, HK827, and
HK838), 4 serotype c (HK342, HK396, HK635, and HK658), 1
serotype d (HK343), 3 serotype e (HK399, HK636, and HK641),
7 serotype f (HK638, HK2055, HK2056, HK2062, HK2063,
HK2065, and HK2109), and 6 non-typeable (HK856, HK2112,
HK2115, HK2117, HK2119, and HK2121) strains. Capsule
production by the 34 reference strains was previously confirmed
by agglutination using burro antisera against serotypes a to f,
provided by Dr. Rachel Schneerson (NIH, Bethesda, MD, United
States) (Table 1).
Preparation of Chromosomal DNA
Genomic DNA was purified from the 50 strains above using
a QIAamp DNA Mini Kit (QIAGEN, Valencia, CA, United
States), in accordance with the manufacturer’s protocol. For the
detection limit study, genomic DNA from five non-Hib serotypes
(IID983, IID985, IID986, IID987, and IID 988) was obtained as
described above and the concentration was determined using
a NanoDrop 1000 instrument (Thermo Fisher Scientific Inc.,
Waltham, MA, United States). The number of genome copies
in the LAMP mixture was calculated based on a molecular
size of 1.83 Mbp (H. influenzae RD KW20; GenBank accession
number, NC000907). To ascertain the detection limit of the
non-Hib LAMP assay, serial tenfold dilutions of genomic DNA
were amplified and the results were compared with those of
conventional PCR (Falla et al., 1994).
In the detection limit study, triplicate non-Hib LAMP testing
was performed over a 3-day period using serial tenfold dilutions
of genomic DNA. The supernatant of pooled H. influenzae-
negative CSF specimens (Anh et al., 2006) was used in a spiking
assay, and serial tenfold dilutions of genomic non-Hib DNA were
amplified by the established LAMP assay.
Non-Hib LAMP Primer Design
Five non-Hib LAMP primer sets were designed based on
published sequences of the non-Hib capsulation loci (GenBank
accession numbers, Z37516, HQ651151, Z33389, HM053635, and
AF549211 for serotypes a, c, d, e, and f, respectively) using
LAMP primer design software (FUJITSU LIMITED, 2016). The
non-Hib LAMP primers included two outer primers (F3 and B3),
a forward inner primer (FIP), a backward inner primer (BIP), and
loop primers (LF and/or LB) (Table 2A).
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TABLE 1 | Reactivity and specificity of the non-Hib serotyping LAMP assay.
Organism Number of strains Origin of isolatea Capsule typeb Non-Hib serotyping LAMP assay
a c d e f
Standard H. influenzae strains (n = 8)d 1 — a +c − − − −
1 — b − − − − −
1 — c − + − − −
1 — d − − + − −
1 — e − − − + −
1 — f − − − − +
2 — nt − − − − −
Reference H. influenzae strains (n = 34)e 5 RT a + − − − −
8 CSF b − − − − −
4 CSF c − + − − −
1 — d − − + − −
3 — e − − − + −
1 CSF f − − − − +
6 RT f − − − − +
6 RT nt − − − − −
aRT, respiratory tract specimen; CSF, cerebrospinal fluid. bCapsule types were confirmed by H. influenzae serotyping PCR (Falla et al., 1994). nt, non-typeable. c+,
positive, amplification after a 35min incubation; −, negative, no amplification after a 60 min incubation. dSource: Institute of Medical Science, University of Tokyo, Tokyo,
Japan. eProvided by Prof. Emeritus Mogens Kilian, Biomedicine, Aarhus University, Aarhus, Denmark.
Non-Hib LAMP Reaction
The reaction mixture (25 µL) contained 1.6 µM each of
FIP and BIP, 0.2 µM each of F3 and B3, 0.4 µM of LF,
8 U of Bst DNA polymerase large fragment (New England
Biolabs, Ipswich, MA, United States), 1.4 mM deoxynucleoside
triphosphates, 0.8 M betaine (Sigma, St. Louis, MO, United
States), 20 mM Tris-HCl (pH 8.8), 10 mM KCl, 10 mM
(NH4)2SO4, 8 mM MgSO4, 0.1% Tween 20, and template DNA
(2 µL). Each serotype reaction mixture was incubated at 63◦C
for 60 min and then heated at 80◦C for 2 min to terminate the
reaction.
Analysis of Non-Hib LAMP Products
A Loopamp real-time turbidimeter (LA-500; Eiken Chemical Co.,
Tokyo, Japan) was used to monitor the turbidity of the reaction
tube in real-time by reading the optimal density at 650 nm
(OD650) at 6-s intervals. The amplification time required to
exceed a turbidity level of 0.1 (Tt) was calculated in accordance
with the manufacturer’s protocol using the turbidimeter software
(Mori et al., 2004).
For the detection limit study, a colorimetric visual inspection
dye (leuco triphenylmethane (Miyamoto et al., 2015); D-QUICK,
Kaneka Co., Osaka, Japan) and a thermostatic color sensor
(MyAbscope R©; Kaneka Co., Osaka, Japan; KANEKA, 2016) were
used. The change in color of the reactions was observed in real
time at 20-s intervals. The amplification time was determined
when an absorbance level exceeded 0.1 using software of the
thermostatic color sensor.
To verify their structure, the amplified LAMP products were
sequenced by Akita Prefectural University Biotechnology Center
using a BigDye R© Terminator V3.1 cycle sequencing kit (Applied
Biosystems, Foster City, CA, United States) and a 3130xL Genetic
Analyzer (Applied Biosystems). The primers used to sequence the
target region are shown in Supplementary Table S1.
Non-Hib PCR Assay
Non-Hib PCR using previously reported primers (Falla et al.,
1994) was performed to type the capsule of H. influenzae strains
(Table 2B). The PCR mixture (25 µL) consisted of 0.2 mM of each
deoxyribonucleoside triphosphate, 10 mM Tris-HCl buffer (pH
8.3), 50 mM KCl, 2 mM MgCl2, 1 U Ex Taq DNA polymerase
(Takara Bio, Tokyo, Japan), 0.5 µM of each primer, and 2 µL
of template DNA. The PCR was performed using two thermal
cyclers: VeritiTM (Applied Biosystems, Foster City, CA, United
States) in Japan and T-100TM (Bio-Rad, Hercules, CA, United
States) in South Korea. The reaction comprised 25 cycles, each
involving 1 min of denaturation at 94◦C, 1 min of annealing at
60◦C, and 1 min of extension at 72◦C. To detect serotype e, the
reaction conditions were modified to use 35 cycles, each involving
30 s of denaturation at 94◦C, 30 s of annealing at 45◦C, and
30 s of extension at 72◦C (Satola et al., 2007). Following the final
cycle, all reactions were incubated for further 10 min at 72◦C.
Products were visualized by resolution in an agarose gel followed
by staining with ethidium bromide.
DNA Spiked Clinical CSF Specimens
To conduct a pilot evaluation of the non-Hib LAMP, seven
bexA PCR-negative specimens were randomly selected from CSF
collected during a 2-year prospective study of bacterial meningitis
in Hanoi (Anh et al., 2006). CSF specimens were pre-treated
at 95◦C for 2 min and centrifuged (13,000 × g, 5 min). The
supernatant of the seven clinical CSF specimens was preserved
for use in DNA-spiked CSF experiments. A 2 µL aliquot of DNA-
spiked CSF specimen was subjected to non-Hib serotyping PCR
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TABLE 2 | (A) LAMP Primer sequences in this study.
Serotyping primer name LAMP primer sequence (sequence 5′-3′; reaction temperature, 63◦C) Length (base pairs)
Serotype a
Hia_F3 ACT CAT TGC AGC ATT TGC 18
Hia_B3 AGA CAC AAT GAA TAT CTT CTG G 22
Hia_FIP CGT GAA CAG GAA TAG TCC ACT CGA AAA TGC GGA TTA TAT TTA CGG 45
Hia_BIP CCT ACA AGG AAC AAA GAC CAT CGG TGA CCG ATG TAT TAA TTT TGC C 46
Hia_LF TTC TTT ATT AAA TTT TTT GAT GCC A 25
Hia_LB AAC TAT TTT TAT CAA TGT CTC CTG G 25
Serotype c
Hic_F3 TGG TTC AGT AGA TGA CTC AG 20
Hic_B3 CTG ATA TTT GTT TAT CGA CTT CAG 24
Hic_FIP GGC TTG CCC ACC ATT TTC TTT ATC TAA GAT TAT TAA AAA TGG CAG CG 47
Hic_BIP TCT GCA AGA AAT GTT GGA ATT GAG CTT TTA CTA ACA AAA TCA TCA GGG TC 50
Hic_LF AGA TAT ATG TGA TAT TTT TAG GAT 24
Hic_LB ACG TTC AAA CCG AAT G 16
Serotype d
Hid_F3 TCG ATA TTT CGT TAG AAC ATC TC 23
Hid_B3 CTA AGA AGA GTT TTA CAA CCA TTC 24
Hid_FIP CTG AAA TGC AGA GGT TAA TTG CAT CCA ACT GCT TTT AAT TCA GAG CC 47
Hid_BIP TCA AAG AAC TCT TTC TTC TTG GGA ATA AAC AGG TTG TAT CGG TCA TC 47
Hid_LB GTA TGA TTA CCT TGT GAT TGA T 22
Serotype e
Hie_F3 ATT GGA AAG GTC GCC GTA 18
Hie_B3 GTA ATA GCT GCC AGT GCT 18
Hie_FIP CTC CAC TGC GAA AAG CTC AAC AAT GGA CAA GTC TAC CTC AA 41
Hie_BIP GAG GGT TCT TTC AAA CTA TTG CTT GGC TTA GGG GTT TCT TCA CT 44
Hie_LB GAC CAA CTT GTC TTA TCA ATC AAC A 25
Serotype f
Hif_F3 TGA GTT ATA CAG TAT CGA TCT C 22
Hif_B3 TGT CAT CTG AAA AAT TTC TAA CGT 24
Hif_FIP ACC CAA GAT AAG AAT TCT CTC TAA TTT ATA TCA ACT TGC TGT TCA A 46
Hif_BIP TTG GAC TTG ATA GTA CCA AAA ACA GTT AGC AAC TAA ATT ACT ACC ATA 48
Hif_LF CAT TCA TCA TTT TAA GTT GGC GTT 24
Hif_LB GGC CTA TTT TTA TGA TAA ACA ACA C 25
TABLE 2 | (B) PCR Primer sequences in this study (Falla et al., 1994).
Serotyping primer name PCR primer sequence (sequence 5′-3′) Length (base pairs)
Serotype a
a1 CTA CTC ATT GCA GCA TTT GC 20
a2 GAA TAT GAC CTG ATC TTC TG 20
Serotype c
c1 TCT GTG TAG ATG ATG GTT CA 20
c2 CAG AGG CAA GCT ATT AGT GA 20
Serotype d
d1 TGA TGA CCG ATA CAA CCT GT 20
d2 TCC ACT CTT CAA ACC ATT CT 20
Serotype e
e1 GGT AAC GAA TGT AGT GGT AG 20
e2 GCT TTA CTG TAT AAG TCT AG 20
Serotype f
f1 GCT ACT ATC AAG TCC AAA TC 20
f2 CGC AAT TAT GGA AGA AAG CT 20
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FIGURE 1 | Visual inspection and dye-mediated monitoring of the H. influenzae serotype-specific LAMP assay. (A), Detection of LAMP reaction using a colorimetric
dye (leuco triphenylmethane; D-QUICK). The results were easily recognized by the naked eye, without UV-lamp. (B), Results of a non-Hib LAMP assay (H. influenzae
type a) using D-QUICK plus MyAbscope R©. Numbers of bacteria decrease from left to right in the figure (100,000 to 1 copy number of DNA per reaction). (C), Linear
regression curve of LAMP results (H. influenzae type a) obtained using D-QUICK plus MyAbscope R©.
and non-Hib serotyping LAMP as described above at Hanyang
University, South Korea.
Ethics Statement
We utilized CSF specimens preserved from our previous
surveillance study (Anh et al., 2006; Kennedy et al., 2007). All
CSF specimens utilized in this study were de-identified prior to
laboratory processing and analysis. Ethical approval for patient
specimen collection during surveillance was obtained from the
following ethics review committees: the Institutional Review
Board of the International Vaccine Institute, Seoul, South Korea;
and the Institutional Review Board at the National Institute of
Hygiene and Epidemiology, Hanoi, Vietnam. Each institution
participated in prospective, population-based surveillance for
childhood meningitis from 1999 to 2002 (Anh et al., 2006;
Kennedy et al., 2007). During those surveillance studies, written
consent was not obtained as the CSF collection was considered
routine standard care for hospitalized children with suspected
bacterial meningitis. For this reason, verbal consent of the parent
or legal guardian present with the child during the period of
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hospitalization was recorded in the patient’s medical chart at the
time of the clinical lumbar puncture procedure. This consent
procedure was approved by these local scientific ethics review
committees of the participating institutions.
RESULTS
The non-Hib LAMP assay for capsular types a, c, d, e,
and f successfully amplified each target sequence of non-Hib
capsulation loci (Table 1). The products were confirmed by
visual inspection of turbidity/color of the reaction tube, real-time
turbidimetry and real-time colorimetric sensor (Figure 1).
Analytical Reactivity and Specificity of
the Non-Hib LAMP
To evaluate the analytical reactivity and specificity of the non-
Hib LAMP primers, we tested 42 H. influenzae strains and 8
non-H. influenzae strains. For each assay mixture, a standard
genomic DNA concentration (105 copies) was used for each
strain. The non-Hib LAMP reaction for capsular types a, c, d, e,
and f amplified each non-Hib target DNA sequence regardless
of the different sources (i.e., respiratory tract or cerebrospinal
fluid specimens). In contrast, genomic DNA of Hib or other
target capsular types was not amplified. Neither non-typeable
H. influenzae nor the eight standard non-H. influenzae species
yielded a positive result in the non-Hib LAMP reaction (Table 1).
Amplification specificity was confirmed by sequencing, and
the sequences were compared with those of the target region in
the original sequence of the non-Hib capsulation locus (between
F1 and B1; Supplementary Figure S1). The sequences obtained
were identical to the expected nucleotide sequences (data not
shown).
Detection Limit of the Non-Hib LAMP
Reaction
The detection limits of the LAMP assays for capsular types a, c,
d, e, and f were 102, 102, 102, 103, and 10 copies per reaction,
while those of the PCR assays were 104, 104, 103, 103, and 104
genome copies per reaction, respectively. Thus, the sensitivity of
the non-Hib LAMP assay was 1–1,000-fold greater than that of
non-Hib PCR (Table 3). The detection limits of each serotype
LAMP assay were identical between the real-time measurement
and direct visual inspection. No amplification was apparent in
the non-Hib LAMP reaction for samples lacking target DNA.
The above results were obtained in triplicate over 3 days and
identical results were obtained in the laboratories in Japan and
South Korea.
The results of LAMP assays using D-QUICK plus
MyAbscope R© are shown in Figure 1. The color change of
the LAMP products was more easily recognized than an increase
in turbidity. The real-time measurement results were used to
generate a linear regression curve with high linearity, while the
observation period was longer than that of real-time turbidimetry
(20-s vs. 6-s intervals) (Figure 1C). The total reaction time of the
two methods was the same (60 min).
LAMP Analysis of DNA-Spiked CSF
Specimens
The detection limit of the non-Hib LAMP assay using DNA
spiked CSF specimens was 10–1,000 genome copies, identical to
that using purified DNA as the template (Table 3). However, that
of the non-Hib PCR worsened from 103 to 104 genome copies
per reaction for serotype d and from 103 to 105 genome copies
per reaction for serotype e. The detection limit of the non-Hib
LAMP assay was identical between direct visual inspection and
real-time measurement.
DISCUSSION
This is the first report of a serotype-specific identification assay
for H. influenzae using the LAMP method. The non-Hib LAMP
assay established in this study accurately identified various
standard and reference non-Hib strains. The non-Hib LAMP
demonstrated an analytical specificity equivalent to that of non-
Hib PCR. Notably, the non-Hib LAMP assay was found to have
a detection limit 1–1,000-fold more sensitive than previously
described non-Hib PCR methods (Falla et al., 1994; Corless
et al., 2001). Although we used spiked CSF samples, the non-
Hib LAMP reaction exhibited sensitivity equivalent to that
when purified DNA was used as the template. However, the
detection limit of the non-Hib PCR for serotypes d and e was
reduced when spiked CSF samples were used. The superior
detection limit and high robustness (Francois et al., 2011) of the
LAMP assay may explain its superior detection limit to that of
non-Hib PCR.
In children under 5 years of age, incidence of invasive non-Hib
diseases has increased globally since the widespread introduction
of Hib vaccines. Notably, in adults 65 years of age and older,
the number of clinical infections with non-Hib strains have also
increased recently (Desai et al., 2015). These studies suggest
that the most common and important non-Hib strain are non-
typeable, and encapsulated non-Hib strains (serotypes a, c, d,
e, and f) began to be reported after the introduction of Hib
vaccination (Dworkin et al., 2007; Resman et al., 2011; Ulanova
and Tsang, 2014). Thus, the incidence of invasive non-Hib
TABLE 3 | Detection limits of LAMP and PCR assays detecting DNAs of non-Hib







PCRa,b LAMPa PCRa,b LAMPa
a 104 copiesc 102 104 copiesc 102
c 104 102 104 102
d 103 102 104 102
e 103 103 105 103
f 104 10 104 10
aPCR results were obtained by electrophoretic analysis. LAMP results were
determined visually. bConventional PCR (Falla et al., 1994). cAmount of DNA per
reaction.
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disease should be monitored and its clinical and epidemiological
characteristics should be thoroughly investigated.
Existing assays for non-Hib infections have notable
limitations. Conventional slide agglutination serotyping tests can
produce misidentifications (LaClaire et al., 2003). However, in
our study, the non-Hib LAMP assay successfully distinguished
each non-Hib serotype strain. The non-Hib LAMP assay used in
this study was analytically specific and had a superior detection
limit to conventional PCR serotyping. Our previous reports of
LAMP assays to detect H. influenzae type b, S. pneumoniae and
N. meningitidis also revealed high sensitivity of the assays. The
detection limits were 10-102 DNA copies per reaction. The high
sensitivity of the novel non-Hib LAMP assay is consistent with
the previous studies (Kim et al., 2011, 2012; Lee et al., 2015a,b).
As the LAMP reaction progresses, the by-product
pyrophosphate ions bind to magnesium ions and form a white
precipitate of magnesium pyrophosphate. The resulting turbidity
can be visualized by the naked eye. This characteristic feature of
the LAMP reaction can be used to detect the reaction end-point,
by identifying the presence of precipitate. The Loopamp real-time
turbidimeter enables quantitative analysis of minute amounts of
nucleic acids (Mori et al., 2004).
In the present study, we assessed the amount of non-Hib
serotype template DNA in real-time using the D-QUICK plus
MyAbscope R©. To our knowledge, this is the first report of a LAMP
assay using D-QUICK plus MyAbscope R© to quantify DNA.
D-QUICK uses leuco triphenylmethane dye, which binds to
double stranded DNA; a positive reaction is indicated by a change
from colorless to violet (Miyamoto et al., 2015). This involves
direct colorimetric detection of LAMP amplified products, rather
than a by-product of the LAMP reaction, and the instrument
measures the absorbance of the reaction in real time at 20-s
intervals (KANEKA, 2016). As shown in Figure 1C, the real-time
measurement had the linear regression curve with high linearity.
Moreover, the simpler real-time absorbance measurement is less
costly than the real-time turbidity measurement.
Previous studies demonstrated that the LAMP reaction is
more tolerant of the presence of potentially perturbing biological
substances (i.e., reaction inhibitors) than PCR (Kaneko et al.,
2007). Therefore, LAMP assays may be suitable in resource-
limited settings in developed and developing countries. The
robust performance of the non-Hib LAMP assay (Francois
et al., 2011) in the present study also suggests that LAMP-based
detection of non-Hib and other invasive bacterial pathogens is
feasible in a wide variety of clinical settings such as hospitals
and health system clinical laboratories. In addition, compared
with non-Hib PCR assays, the non-Hib LAMP assay has greater
analytical sensitivity and less likely to miss clinical disease caused
by non-Hib infections.
Our laboratory’s experience with the non-Hib LAMP
and LAMP for the detection of other pathogens, such as
S. pneumoniae, suggests that the cost of the non-Hib LAMP assay
per specimen tested is markedly lower than that of PCR, and can
be performed in laboratories with limited technology. Prospective
studies of the non-Hib LAMP assay using clinical specimens that
are now underway will confirm the assay’s sensitivity, specificity,
predictive values, and likelihood ratios compared with bacterial
culture, antigen detection, and PCR.
In summary, we have successfully established a LAMP-based
non-Hib DNA amplification method and confirmed its superior
analytical specificity and detection limit. Compared with PCR-
based detection methods, this assay enables the detection of non-
Hib serotypes with high sensitivity. Because the LAMP reaction is
easy to set-up and does not require specialized equipment, it has
obvious advantages in clinical settings and in population-based
studies with limited access to well-equipped laboratories.
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